Therapeutic Goods Administration
The Therapeutic Goods Administration or TGA is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. It is a Division of the Australian Department of Health and Ageing established under the Therapeutic Goods Act 1989 (Cth). The TGA is responsible for conducting assessment and monitoring activities to ensure that therapeutic goods available in Australia are of an acceptable standard and that access to therapeutic advances is in a timely manner.
TGA Branches
The TGA is divided into a number of Branches, including:
- Drug Safety and Evaluation Branch (DSEB), responsible for regulating prescription medicines
- Non-prescription Medicines Branch (NPMB), responsible for regulating over-the-counter and complementary medicines
- Office of Devices, Blood and Tissues (ODBT)
- Office of the Gene Technology Regulator (OGTR)
TGA Expert Advisory Committees
The TGA is supported in its work by a number of external expert advisory committees, including:
- Australian Drug Evaluation Committee (ADEC) - for prescription medicines
- Adverse Drug Reactions Advisory Committee (ADRAC)
- Medicines Evaluation Committee (MEC) - for over-the-counter medicines
- Complementary Medicines Evaluation Committee (CMEC) - for complementary medicines
- Therapeutic Devices Evaluation Committee (TDEC) - for medical devices
- National Drugs and Poisons Scheduling Committee (NDPSC)
- Therapeutic Goods Committee (TGC)
Trans-Tasman harmonisation
The governments of Australia and
See also
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
- Standard for the Uniform Scheduling of Drugs and Poisons
- Australia New Zealand Therapeutic Products Authority
External links
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
